Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin effects on OPG/RANKL/RANK in osteoporotic hypercholesterolemic women
2007-005618-38Phase 4Completed
- Sponsor
- AULSS n. 2 Marca Trevigiana
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atorvastatin in osteoporosis and hypercholesterolemia, sponsored by AULSS n. 2 Marca Trevigiana. Primary endpoint: OPG/RANKL/RANK expression on peripheral blood mononuclear cells. Started Feb 2008; status: completed.
02
Drugs
atorvastatin
03
Conditions
osteoporosishypercholesterolemia
Beyond the preview
Go deeper on 2007-005618-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005618-38.